Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD+ to eradicate

Ang Jia1, Xiaowen Zhang2, Ji-Hao Zhou3

  • 1Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Drug Clinical Trial Center, Shanghai Xuhui Central Hospital, Zhongshan-Xuhui Hospital, Fudan University, Institute of Clinical Mass Spectrometry, Shanghai Academy of Experimental Medicine, Shanghai, China; State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China.

Cell Metabolism
|January 30, 2026
PubMed

Insights

New research identifies Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations as key drivers of aggressive Acute Myeloid Leukemia (AML). A novel dual-targeting compound selectively eliminates KRAS-mutant AML cells by disrupting mitochondrial NAD+ metabolism.

Area of Science:

  • Oncology
  • Molecular Biology
  • Metabolic Pathways

Background:

  • Acute Myeloid Leukemia (AML) heterogeneity complicates treatment, with aggressive drivers often remaining unidentified.
  • Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations are implicated in hyperproliferative and therapy-resistant AML, but current inhibitors show limited efficacy.

Purpose of the Study:

  • To identify novel therapeutic targets and strategies for KRAS-mutant AML.
  • To investigate the metabolic vulnerabilities associated with KRAS-driven AML.

Main Methods:

  • Utilized dual physiological/glucose-deprived screening to identify selective cytotoxic compounds.
  • Investigated the mechanism of action of compound 615, focusing on succinate dehydrogenase (SDH) and SLC25A51 inhibition.
  • Analyzed mitochondrial NAD+ metabolism and protein succinylation in KRAS-mutant versus wild-type AML cells.

Main Results:

  • Compound 615 selectively eliminates KRAS-mutant AML cells by inhibiting both SDH and the mitochondrial NAD+ transporter SLC25A51.
  • KRAS-mutant cells exhibit reduced SLC25A51 succinylation, creating a synthetic lethal vulnerability exploited by compound 615.
  • Dual inhibition leads to catastrophic mitochondrial NAD+ depletion in KRAS-mutant cells, while KRAS-wild-type cells maintain NAD+ homeostasis.

Conclusions:

  • KRAS mutations confer a specific metabolic vulnerability in AML related to mitochondrial NAD+ transport.
  • Compound 615 represents a promising dual-inhibition therapeutic strategy for KRAS-driven AML.
  • Understanding KRAS-specific metabolic dependencies opens new avenues for targeted AML therapies.

Related Concept Videos

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.2K
Export of Mitochondrial and Chloroplast Genes02:19

Export of Mitochondrial and Chloroplast Genes

A eukaryotic cell can have up to three different types of genetic systems: nuclear, mitochondrial, and chloroplast. During evolution, organelles have exported many genes to the nucleus; this transfer is still ongoing in some plant species. Approximately 18% of the Arabidopsis thaliana nuclear genome is thought to be derived from the chloroplast’s cyanobacterial ancestor, and around 75% of the yeast genome derived from the mitochondria’s bacterial ancestor. This export has occurred...
4.2K
The Citric Acid Cycle02:36

The Citric Acid Cycle

The citric acid cycle, also known as the Krebs cycle or TCA cycle, consists of several energy-generating reactions that yield one ATP molecule, three NADH molecules, one FADH2 molecule, and two CO2 molecules.
162.1K
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes02:16

Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...
16.0K
MOSFET: Depletion Mode01:20

MOSFET: Depletion Mode

Depletion-mode MOSFETs represent a unique subset of MOSFET technology, functioning fundamentally differently from their enhancement-mode counterparts. Unlike enhancement MOSFETs, which require a positive gate-source voltage (Vgs) to turn on, depletion-mode MOSFETs are inherently conductive and "normally on" devices.
The primary characteristic of depletion-mode MOSFETs is their ability to conduct current between the drain and source terminals without gate bias. This inherent conductivity...
860
What is Natural Selection?01:32

What is Natural Selection?

Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
129.0K